HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabetta Caselli Selected Research

KIR2DL2 Receptors

2/2022Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity.
10/2012Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabetta Caselli Research Topics

Disease

26Infections
02/2022 - 08/2002
7Virus Diseases (Viral Diseases)
01/2021 - 08/2002
4COVID-19
01/2022 - 08/2020
3Inflammation (Inflammations)
01/2021 - 04/2007
3Multiple Sclerosis
12/2016 - 11/2002
2Fibrosis (Cirrhosis)
01/2021 - 12/2019
2Infertility (Sterility)
01/2020 - 01/2020
2Flushing
01/2020 - 01/2016
2Herpesviridae Infections (Herpesvirus Infection)
07/2016 - 10/2014
1Autoimmune Diseases (Autoimmune Disease)
12/2021
1Disease Progression
01/2021
1Cytokine Release Syndrome
08/2020
1Viral Pneumonia
08/2020
1Thrombosis (Thrombus)
08/2020
1Bites and Stings (Sting)
01/2020
1Uterine Cervical Dysplasia
01/2020
1Choriocarcinoma
01/2020
1Dysbiosis
01/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2019
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
11/2017
1Neoplasms (Cancer)
07/2017
1Breast Neoplasms (Breast Cancer)
07/2017
1Type 2 Diabetes Mellitus (MODY)
10/2014
1Hypoxia (Hypoxemia)
08/2012
1Kaposi Sarcoma (Kaposi's Sarcoma)
01/2008
1HIV Infections (HIV Infection)
10/2005
1Herpes Genitalis (Genital Herpes)
01/2005

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2021 - 01/2016
5Proteins (Proteins, Gene)FDA Link
11/2020 - 03/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2003
4MicroRNAs (MicroRNA)IBA
01/2021 - 01/2017
4HLA-G Antigens (HLA G)IBA
12/2019 - 09/2015
3LigandsIBA
02/2022 - 10/2014
3Biological ProductsIBA
08/2020 - 08/2002
2KIR2DL2 ReceptorsIBA
02/2022 - 10/2012
2Immunoglobulins (Immunoglobulin)IBA
01/2021 - 11/2020
2Immunoglobulin A (IgA)IBA
01/2021 - 11/2020
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017 - 08/2002
2Transcription Factors (Transcription Factor)IBA
01/2017 - 08/2012
2KIR ReceptorsIBA
07/2016 - 10/2014
2AntibodiesIBA
02/2013 - 11/2002
2Activating Transcription Factor 4IBA
08/2012 - 01/2012
2AntigensIBA
01/2003 - 11/2002
1Disinfectants (Biocides)IBA
01/2022
1AutoantigensIBA
12/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Secretory Immunoglobulin A (SIgA)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
11/2020
1Interleukin-6 (Interleukin 6)IBA
08/2020
1A-factor (Streptomyces)IBA
01/2020
1Histidine (L-Histidine)FDA Link
01/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1InterleukinsIBA
01/2020
1Nucleic AcidsIBA
01/2020
1Tyrosine (L-Tyrosine)FDA Link
01/2020
1Complementary DNA (cDNA)IBA
01/2020
1Purinergic P2X7 ReceptorsIBA
01/2020
1Amyloid beta-PeptidesIBA
12/2019
1Threonine (L-Threonine)FDA Link
12/2019
1RNA (Ribonucleic Acid)IBA
12/2019
1Apolipoproteins E (ApoE)IBA
12/2019
1Viral DNAIBA
12/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Protein Isoforms (Isoforms)IBA
12/2018
1Chemokine ReceptorsIBA
01/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1Chemokine CCL26IBA
01/2017
13' Untranslated Regions (3' UTR)IBA
12/2016
1Interleukin-10 (Interleukin 10)IBA
01/2016
1Histocompatibility Antigens Class IIIBA
01/2012
1RetinoidsIBA
01/2008
1Monocyte Chemoattractant ProteinsIBA
04/2007
1NF-kappa B (NF-kB)IBA
04/2007
1Trans-Activators (Trans-Acting Factor)IBA
10/2005
1tat Gene Products (tat Protein)IBA
10/2005
1Glycoproteins (Glycoprotein)IBA
01/2005
1VaccinesIBA
01/2005
1Subunit VaccinesIBA
01/2005
1EnzymesIBA
11/2002
1ImmunosorbentsIBA
11/2002
1ChemokinesIBA
08/2002
1Interleukin-8 (Interleukin 8)IBA
08/2002

Therapy/Procedure

2Therapeutics
01/2021 - 01/2019
1Hand Hygiene
08/2020
1Drug Therapy (Chemotherapy)
01/2019